1617 An observational time and motion study of denosumab subcutaneous injection and zoledronic acid intravenous infusion in patients with metastatic bone disease: Results from Belgium and Germany. (September 2015) - Body, J.J.; Gatta, F.; Peteers, M.; Wimberger, P.; Mebis, J.; Sommer, U.; Besse-Hammer, T.; De Cock, E.; Tao, S.; Kritikou, P.; Hechmati, G.